Baldassano R - Search Results

1

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension.

Hyams J, Walters TD, Crandall W, Kugathasan S, Griffiths A, Blank M, Johanns J, Lang Y, Markowitz J, Cohen S, Winter HS, Veereman-Wauters G, Ferry G, Baldassano R. Hyams J, et al. Among authors: baldassano r. Curr Med Res Opin. 2011 Mar;27(3):651-62. doi: 10.1185/03007995.2010.547575. Epub 2011 Jan 18. Curr Med Res Opin. 2011. PMID: 21241207 Clinical Trial.

2

Failure of single-toxin assays to detect clostridium difficile infection in pediatric inflammatory bowel disease.

Markowitz JE, Brown KA, Mamula P, Drott HR, Piccoli DA, Baldassano RN. Markowitz JE, et al. Among authors: baldassano rn. Am J Gastroenterol. 2001 Sep;96(9):2688-90. doi: 10.1111/j.1572-0241.2001.04125.x. Am J Gastroenterol. 2001. PMID: 11569696

3

Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Baldassano R, Ferry G, Griffiths A, Mack D, Markowitz J, Winter H. Baldassano R, et al. J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):245-8. doi: 10.1097/00005176-200203000-00001. J Pediatr Gastroenterol Nutr. 2002. PMID: 11964946 No abstract available.

4

Infliximab as a novel therapy for pediatric ulcerative colitis.

Mamula P, Markowitz JE, Brown KA, Hurd LB, Piccoli DA, Baldassano RN. Mamula P, et al. J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):307-11. doi: 10.1097/00005176-200203000-00017. J Pediatr Gastroenterol Nutr. 2002. PMID: 11964959

5

Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease.

Batres LA, Mamula P, Baldassano RN. Batres LA, et al. J Pediatr Gastroenterol Nutr. 2002 May;34(5):558-60. doi: 10.1097/00005176-200205000-00016. J Pediatr Gastroenterol Nutr. 2002. PMID: 12050585 No abstract available.

6

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center.

Stephens MC, Shepanski MA, Mamula P, Markowitz JE, Brown KA, Baldassano RN. Stephens MC, et al. Am J Gastroenterol. 2003 Jan;98(1):104-11. doi: 10.1111/j.1572-0241.2003.07161.x. Am J Gastroenterol. 2003. PMID: 12526944

7

Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease.

Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, Winter HS. Baldassano R, et al. Am J Gastroenterol. 2003 Apr;98(4):833-8. doi: 10.1111/j.1572-0241.2003.07343.x. Am J Gastroenterol. 2003. PMID: 12738464 Clinical Trial.

8

Infliximab in pediatric ulcerative colitis: two-year follow-up.

Mamula P, Markowitz JE, Cohen LJ, von Allmen D, Baldassano RN. Mamula P, et al. J Pediatr Gastroenterol Nutr. 2004 Mar;38(3):298-301. doi: 10.1097/00005176-200403000-00013. J Pediatr Gastroenterol Nutr. 2004. PMID: 15076630

9

CDP571, a humanized anti-tumor necrosis factor-alpha monoclonal antibody in pediatric Crohn's disease.

Mamula P, Cohen SA, Ferry GD, Kirschner BS, Winter HS, Innes A, Patel J, Baldassano RN; Pediatric Inflammatory Bowel Disease Consortium. Mamula P, et al. Inflamm Bowel Dis. 2004 Nov;10(6):723-30. doi: 10.1097/00054725-200411000-00005. Inflamm Bowel Dis. 2004. PMID: 15626889 Clinical Trial.

10

Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, Winter HS, Fain P, King C, Smith T, El-Serag HB. Heyman MB, et al. Among authors: baldassano r. J Pediatr. 2005 Jan;146(1):35-40. doi: 10.1016/j.jpeds.2004.08.043. J Pediatr. 2005. PMID: 15644819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters